Evidence map›Paper›PMID 34298598›Full record

ReviewCancers2021

Genomic, Microbial and Immunological Microenvironment of Colorectal Polyps.

Benita C Y Tse, Zoe Welham, Alexander F Engel, Mark P Molloy

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Colorectal cancer: local results and significance in Hungary.Journal of gastrointestinal oncology · 2024
    Article
  9. Article
  10. Advances in Mapping Tumor Progression from Precancer Atlases.Cancer prevention research (Philadelphia, Pa.) · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Benita C Y TseBowel Cancer and Biomarker Laboratory, Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Zoe WelhamBowel Cancer and Biomarker Laboratory, Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.
Alexander F EngelDepartment of Colorectal Surgery, Royal North Shore Hospital, Sydney 2065, Australia.
Mark P MolloyBowel Cancer and Biomarker Laboratory, Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney 2006, Australia.ORCID 0000-0003-4679-5868
The University of Sydney · AU

Funding

Cancer Council NSW RG20-10Tour de Cure RSP222-20
6 · The paper itself

Abstract

Colorectal cancer (CRC) develops from pre-cancerous cellular lesions in the gut epithelium, known as polyps. Polyps themselves arise through the accumulation of mutations that disrupt the function of key tumour suppressor genes, activate proto-oncogenes and allow proliferation in an environment where immune control has been compromised. Consequently, colonoscopic surveillance and polypectomy are central pillars of cancer control strategies. Recent advances in genomic sequencing technologies have enhanced our knowledge of key driver mutations in polyp lesions that likely contribute to CRC. In accordance with the prognostic significance of Immunoscores for CRC survival, there is also a likely role for early immunological changes in polyps, including an increase in regulatory T cells and a decrease in mature dendritic cell numbers. Gut microbiotas are under increasing research interest for their potential contribution to CRC evolution, and changes in the gut microbiome have been reported from analyses of adenomas. Given that early changes to molecular components of bowel polyps may have a direct impact on cancer development and/or act as indicators of early disease, we review the molecular landscape of colorectal polyps, with an emphasis on immunological and microbial alterations occurring in the gut and propose the potential clinical utility of these data.

Indexed as

adenomacolonoscopycolorectal carcinomacolorectal polypsimmunogenicmicrobiomemutational burden

Identifiers

PMID34298598
PMCPMC8303543
OpenAlexW3181858723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.